Home›Companies›Biotech & Pharma›Cascade Biocatalysts

Cascade Biocatalysts, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 25, 2025·Suggest an edit

About Cascade Biocatalysts

Cascade Biocatalysts is a private company based in Denver, Colorado, incorporated in 2022 in Delaware. It has reported $5,441,785 raised in one offering on Form D since August 2025. Its chief executive is Alexander Rosay.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 8, 2025Aug 25, 2025$5,441,785of $5.6M target41$132KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cascade Biocatalysts's Form D filed Aug 25, 2025.

AR
Alexander Rosay
Chief Executive Officer and director
JW
James Weltz
Executive officer, director and promoter
JC

Sources

  1. SECCascade Biocatalysts, Inc. filing history